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3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, commonly known as statins, are the medical
treatment of choice for hypercholesterolemia. In addition to lowering serum-cholesterol levels, statins appear to promote
pleiotropic eﬀects that are independent of changes in serum cholesterol. In this study, we investigated the eﬀects of low-dose
ﬂuvastatin on antioxidant enzyme activities (superoxide dismutase, SOD; catalase), total nitrite/nitrate levels, and vascular
reactivity in 2% cholesterol-fed rabbits. This diet did not generate any fatty streak lesions on carotid artery wall. However,
SOD activity signiﬁcantly increased with cholesterol feeding whereas the catalase activities decreased. The levels of nitrite/nitrate,
stable products of NO degradation, diminished. Moreover, dietary cholesterol reduced vascular responses to acetylcholine, but
contractionstoserotoninwereaugmented.Fluvastatintreatmentabrogatedthecholesterol-inducedincreaseinSOD,increasedthe
levels of nitric oxide metabolites in tissue, and restored both the impaired vascular responses to acetylcholine and the augmented
contractile responses to serotonin without aﬀecting plasma-cholesterol levels. Phenylephrine contractions and nitroglycerine
vasodilatations did not change in all groups. This study indicated that ﬂuvastatin treatment performed early enough to improve
impaired vascular responses may delay cardiovascular complications associated with several cardiovascular diseases.
1.Introduction
Oxidative stress and endothelial dysfunction in the coronary
and peripheral circulation have important prognostic impli-
cations for subsequent cardiovascular events [1]. Chronic el-
evations in serum cholesterol are often associated with an
impaired endothelium-dependent vasodilation before the
appearance of any ultrastructural change in the vessel wall
of patients with risk for atherosclerosis [2]. This eﬀect of
hypercholesterolemia is due to the combination of increased
oxidative stress leading to a reduced bioavailability of NO,
impairment of the turnover rate of eNOS, and augmented
levels of circulating asymmetric dimethyl arginine (ADMA,
an endogenous inhibitor of eNOS) [3] .I no r d e rt op r o t e c t
tissues from the damaging eﬀects of oxidative stress, the or-
ganism possesses enzymatic and nonenzymatic antioxidant
systems [4]. It has been suggested that a chronic imbalance
between formation of reactive oxygen species (ROS) and an-
tioxidant capacity characterizes many disease states, such as
atherosclerosis, carcinogenesis, and reperfusion injury [5,
6]. In opposition to endothelium-dependent relaxation re-
sponses, the vascular smooth muscle responsiveness is con-
troversial in experimental hypercholesterolemia [7, 8].
HMG-CoA reductase inhibitors (statins) reduce choles-
terol levels and prevent cardiovascular morbidity and mor-
tality [9]. These drugs also exert beneﬁts not related to
the reduction of cholesterol levels; these are known as
pleiotropic eﬀects [10] .S e v e r a ls t u d i e sh a v ed e m o n s t r a t e d
that independent of lipid lowering eﬀects, ﬂuvastatin has
an antioxidant eﬀect, decreases expression of adhesion mol-
ecules in monocytes and leukocyte-endothelium adherence
responses, inhibits cholesterol esteriﬁcation and accumula-
tion in macrophages, along with eﬀects on smooth muscle
cell proliferation and migration [11]. Up to date there is2 The Scientiﬁc World Journal
no evidence that HMG-CoA reductase inhibitors exert pro-
tective eﬀects on early-stage vascular functions with a high-
cholesterol diet.
The present study aims to investigate the potential effects
of ﬂuvastatin, at a dose insuﬃcient to cause the lipid-low-
ering eﬀect, on antioxidant systems (superoxide dismutase:
SOD, catalase) and nitrite/nitrate levels and the early-
stage vascular functions in rabbits fed with 2% cholesterol-
enriched diet for 4 weeks.
2.MaterialsandMethods
2.1. Materials. Cholesterol was purchased from Fluka
(Buchs, Switzerland). Drugs for functional studies such
as acetylcholine hydrochloride, phenylephrine hydrochlo-
ride, 5-hydroxytryptamine creatinine sulphate, Nω-nitro-L-
arginine, and indomethacin were purchased from Sigma
Chemical Co., (St. Louis, Mo, USA). Nitroglycerine solution
was obtained from Merck, Sharp, and Dohme (Munich, Ger-
many) and sodium pentobarbital from Psyphac (Brussels,
Belgium).
2.2. Animals and Study Design. Animals were obtained from
the Animal Breeding Facility of the Faculty of Pharmacy. The
study had been approved by Animals Ethics Committee of
the Faculty of Pharmacy of Ege University. White rabbits
of either sex (n = 15) were divided into 3 groups. Control
group was given a regular rabbit chow; cholesterol group was
fed a regular rabbit chow plus 2% cholesterol; ﬂuvastatin
group received regular rabbit chow plus 2% cholesterol
and ﬂuvastatin (2mg/kg/day, p.o.). Animals in all treatment
groups consumed 100g of chow daily. Each rabbit was kept
in a separate cage and allowed access to tap water ad libitum.
Each treatment was continued for 4 weeks. Weights were
recorded every day. Blood samples were drawn from the
centraleararteryatthebeginning andthe end ofthe studyto
measure plasma cholesterol levels. Rabbits were sacriﬁced by
an overdose of sodium pentobarbital (100mg/kg) at the end
of the feeding period. The carotid arteries were excised and
dissected free of adhering adipose and connective tissue. Left
carotidarterywascutinto3mmringsfororganbathstudies,
and the right carotid artery was used for morphological and
biochemical experiments. Tissue samples after being frozen
under liquid nitrogen were stored at −80◦C prior to analysis.
On the day of analysis, the proximal carotid artery was cut
into transverse sections and stained with ORO (Oil Red O)
for morphometric analysis.
2.3. Biochemical Analyses
2.3.1. Cholesterol Measurements. Plasma total cholesterol
levels were determined with commercially available enzyme
kits (Lieberman-Burchard, G-200 Cholesterol kit, G¨ okhan
Lab. Tic. A.S ¸.I z m i r ,T u r k e y ) .T h e s el e v e l sw e r ee x p r e s s e da s
mmol/L.
2.3.2. Measurements in Tissue Samples. The right carotid
arteries were homogenized in phosphate buﬀer saline
(pH = 7.4) in a ratio of 1/10 (w/v) and centrifuged at 600g
for 10min; the supernatant was used for SOD, catalase assay,
and measurement of nitrite/nitrate levels. SOD and catalase
activities were determined as described previously [12].
Protein concentrations were measured using bovine-serum
albumin as a standard by the method of Lowry et al. [13].
Nitrite levels were determined by a colorimetric method
based on the Sozmen et al. [14] .N i tra t el ev e l sw e r em e a s u r e d
by the enzymatic reduction of nitrate to nitrite by nitrate
reductase from Aspergillus sp., in the presence of NADPH
[15]. Oxidation of NADPH was recorded as the decrease in
absorbance at 340nm. Sodium nitrite and nitrate solutions
were used for standard measurements. Tissue nitrate, nitrite,
and total nitrite/nitrate levels were expressed as nmol/mg
protein.
2.4. Organ Bath Experiments. Carotid artery rings were
mounted on stainless steel wires connected to force trans-
ducers and placed in organ chambers for isometric tension
recording and examined for vascular reactivity.
Studies were performed in organ chambers ﬁlled with
25mL Kreb’s physiological salt solution (PSS) with the
following composition (mM): NaCl, 118.0; KCl, 4.7; CaCl2,
2.5; KH2PO4,1 . 2 ;M g S O 4,1 . 2 ;N a H C O 3, 25.0; glucose,
11.1 and equilibrated at 37◦C with 95% O2-5% CO2 gas
mixture. Tension was measured isometrically with a Grass
FT 3 force transducer and recorded by IOSlab software
package (IOS lab version 3.23 MS8, EMKA Technologies,
Paris, France) using a 80486-based microcomputer (IBM
PS/1, U.K.). Passive tension was gradually increased and
adjustedto7g,whichbringsbothcontrolandatherosclerotic
carotid artery to the optimal length forisometric contraction
[16]. The segments were then allowed to equilibrate for
45min prior to experimentation. During the equilibration
period, the bath solution was changed every 15min. At the
end of this period tissues were contracted with 80mM KCl
to determine the contractility. Then, tissues were washed
out three times and acetylcholine-induced endothelium-
dependent, vasorelaxant responses resulting from the release
of nitric oxide were tested. For this purpose, carotid artery
rings were contracted with phenylephrine (10−6M), and
during plateau contraction, acetylcholine (ACh) was added
in a cumulative manner (10−9M–10−4M). Tissues which
relaxed by more than 45% of the initial contraction were
accepted as endothelium intact and washed out three times
with PSS, recontracted with phenylephrine (10−6M), and
then exposed to cumulative concentrations of nitroglycerine
(NTG) (10−9M × 10−5M). Later, the tissues were washed
out three times and treated with cumulative concentrations
of phenylephrine (10−9M–10−4M) and serotonin (5-HT)
(10−9M × 10−5M). Each agonist was washed out by
changing the bath solution three times within 30min before
addition of the next agonist. Thereafter, the concentration-
response curves of phenylephrine (10−9M–10−4M) and 5-
HT (10−9M × 10−5M) were obtained in arterial rings fol-
lowingincubationoftissueswithNω-nitro-L-arginine(LNA;
10−4M, 30min), a competitive inhibitor of constitutive and
inducible nitric oxide synthase (NOS) isoforms, cyclooxyge-
nase inhibitor indomethacin (INDO; 10−5M, 30min) [17].The Scientiﬁc World Journal 3
Table 1: Body weights and plasma total cholesterol levels from all groups of rabbits.
Control group Cholesterol group Cholesterol + ﬂuvastatin group
Body weight (kg) Start 2.64 ± 0.08 2.69 ± 0.13 2.67 ± 0.07
End 2.77 ± 0.09 2.56 ± 0.09 2.50 ± 0.07
Plasma total cholesterol (mmol/L) Start 0.94 ± 0.15 1.30 ± 0.18 1.02 ± 0.18
End 1.20 ± 0.13 13.82 ± 1.88+ 9.40 ± 1.07∗
+P<0.001, control versus cholesterol and ∗P<0.01 control versus cholesterol + ﬂuvastatin, ANOVA followed by Bonferroni post hoc test. Data are expressed
as means of ﬁve independent measurements using ﬁve animals in each group. Data are given ± S.E.M.
Table 2: Antioxidant enzyme activities and total nitrite/nitrate levels in carotid artery tissues from all groups.
Control group Cholesterol group Cholesterol + ﬂuvastatin group
SOD (U/g protein) 1.56 ± 0.25 4.60 ± 0.41 + 3.36 ± 0.12 ∗
Catalase (U/g protein) 2.13 ± 0.34 0.74 ± 0.08 + 1.24 ± 0.23
Total nitrite/nitrate (nmol/mg protein) 723.90 ± 18.98 308.80 ± 1.80 + 705.20 ± 7.19 ∗
+P<0.001, control versus cholesterol and ∗P<0.05, cholesterol versus cholesterol + ﬂuvastatin in SOD, and +P<0.01, control versus cholesterol in
catalase antioxidant enzyme activities. +P<0.001, control versus cholesterol and ∗P<0.001 cholesterol versus cholesterol + ﬂuvastatin in total nitrite/nitrate
(NO2
−/NO3
−) levels of carotid artery tissues. Data are given ± S.E.M. ANOVA followed by Bonferroni post hoc test. Data are expressed as means of ﬁve
independent measurements using ﬁve animals in each group.
2.5. Statistical Analysis. A l lv a l u e sa r eg i v e na sm e a n s±
S.E.M. The number of experiments refers to the number of
animals. ACh- and NTG-induced relaxations were normal-
ized to the phenylephrine precontractions and expressed as
percentage. The negative logarithm of concentration (−log
EC50 or pD2) that produced half of the maximal eﬀect
(Emax) of that agonist was calculated. Prism 3.02 (GraphPad
Software, USA) was used for this purpose. All data were
analysed by using the SPSS/PC+ package (SPSS, Chicago,
Ill, USA) programme. The statistical comparisons between
the groups were tested using one-way analysis of variance
(ANOVA) followed by Bonferroni for multiple comparisons.
The diﬀerences between tensions developed to Nω-nitro-L-
arginine (LNA) and indomethacin (INDO) in the groups
wereassessedbyWilcoxonpairedsignedrankstest.Statistical
signiﬁcance was accepted at the 0.05 level of probability.
3. Results
3.1. Animals and Plasma-Cholesterol Levels. The body
weights of animals were not diﬀerent either from each other
at the beginning and the end of the experimental protocol or
betweenthegroups(Table 1).Initialplasmacholesterollevels
were not signiﬁcantly diﬀerent among the three groups.
Cholesterol feeding increased plasma cholesterol levels at the
end of 4 weeks and ﬂuvastatin treatment (2mg/kg/day) did
not lower the plasma cholesterol levels (Table 1).
3.2. Morphological Alterations of Carotid Artery. Lipid inﬁl-
tration was not observed in carotid artery sections of
cholesterol and cholesterol diet plus ﬂuvastatin groups after
staining with ORO (Oil Red O) (Figure 1).
3.3. Antioxidant Enzyme Activities in Carotid Tissues. While
tissue catalase activity was decreased, the SOD activity was
increased at the end of the 4 week cholesterol feeding pe-
riod. However, treatment with ﬂuvastatin did not aﬀect
the catalase activity but lowered the increased activity of
SOD in cholesterol group (Table 2). Tissue NO metabolites
(NO2
− and NO3
−) were also determined in carotid artery
tissues. Cholesterol feeding signiﬁcantly decreased total
nitrite/nitrate levels and ﬂuvastatin treatment reversed the
decrease in nitrite/nitrate levels (Table 2).
3.4. Vascular Reactivity. 80mM KCl-induced contractions
were aﬀected by neither cholesterol feeding nor ﬂuvastatin
treatment (Figure 2). 5-HT and phenylephrine induced
concentration-dependent contractions in the carotid artery
rings of all groups (Figure 3). Cholesterol feeding caused
an increase of 5-HT contractions and ﬂuvastatin treatment
normalizedtheaugmentedvascularresponsestothisagonist.
Besides, in rings from ﬂuvastatin group, in the pres-
ence of LNA, 5-HT-induced contractions were signiﬁcantly
increased, indicating the contribution of endothelial nitric
oxidetotheeﬀectofﬂuvastatin(Figures4(a),4(b),and4(c)).
However, the contractile responses of this agonist were not
changed in the presence of indometacin (Figures 4(d), 4(e),
and 4(f)). On the other hand, the Emax and pD2 values of
phenylephrine were not changed in all groups (Figure 3).
ACh and NTG induced concentration-dependent relax-
ations in carotid artery rings from all groups (Figure 3). In
the cholesterol group, relaxations to ACh were signiﬁcantly
impaired as compared to control group and treatment with
ﬂuvastatin signiﬁcantly restored these reduced relaxations.
Cholesterol feeding and ﬂuvastatin treatment did not aﬀect
the Emax and pD2 values of nitroglycerine (Figure 3).
4. Discussion
It has been demonstrated that the preventive eﬀect of statins
on coronary events is not only attributed to cholesterol-
lowering, but also to various eﬀects on the vascular wall,4 The Scientiﬁc World Journal
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Figure 1: Photomicrographs of the proximal common carotid artery of the right side staining with Red-Oil. Original magniﬁcation ×100.
Carotid artery from (a) control group; (b) cholesterol group; (c) cholesterol + ﬂuvastatin group.
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Figure 2: 80mM KCl-induced contractions in carotid arteries from
all groups. Data shown in bar graphs are expressed as mean ±
S.E.M.
which include improved endothelial function as well as
antioxidant and anti-inﬂammatory activity [18–20]. In this
study, pleiotropic eﬀects of ﬂuvastatin on alterations in
vascular reactivity and antioxidant enzyme activities and
total nitrite/nitrate levels were examined by assessing the
responses of carotid arteries of rabbits fed with 2% cho-
lesterol-enriched diet for 4 weeks.
In the present study, cholesterol feeding did not show
any fatty streak lesion in carotid arteries as demonstrated
by Red-Oil staining. It is well known that in rabbits, the
aorta, the pulmonary, and carotid arteries are susceptible
to atherosclerosis [21, 22]. However, in the experimental
models of atherosclerosis, the inﬂuence of varying peri-
ods of cholesterol feeding on plaque formation has been
demonstrated [21]. Thus, in our study, short-term (4 weeks)
cholesterol feeding resulted in the functional alteration of
endothelial responses (c.f. infra) without inducing plaque
formation, suggesting the time dependency of the formation
of lesions to cholesterol feeding. On the other hand, it has
been reported that endothelial dysfunction precedes vascular
wall lesions in the early phase of hypercholesterolemia [23].
The term endothelial dysfunction commonly refers to a
reduced endothelium-dependent vasodilator capacity of the
arteries to acetylcholine [24]. Since it is known that this
type of vasorelaxation is related to the production of nitric
oxide from endothelial cells, endothelial dysfunction is typ-
ically attributed to a decreased production, and/or increasedThe Scientiﬁc World Journal 5
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Figure 3: The eﬀect of cholesterol feeding and ﬂuvastatin treatment on vascular contractions to serotonin (a) and phenylephrine (b) and
relaxations to acetylcholine (c) and nitroglycerine (d) in isolated rabbit carotid artery. Rings of carotid arteries from control ()( n = 5),
cholesterol ()( n = 5), and cholesterol + ﬂuvastatin ()( n = 5) groups. Values are expressed as means ± S.E.M. Cumulative dose-response
curves for ACh and NTG precontracted with 10−6M phenylephrine. P<0.01 compared with control versus cholesterol (∗) and cholesterol
versus cholesterol + ﬂuvastatin (+) groups, ANOVA followed by Bonferroni post hoc test.
catabolism of the endothelium-derived NO [24]. During
the past 20 years, several studies have shown that hyperc-
holesterolemia induces macrovascular endothelial dysfunc-
tion [22, 25]. In accordance with these ﬁndings, the
results of our study showed that ACh-induced receptor-
mediated, endothelium-dependent responses were impaired
in the carotid artery of cholesterol-fed rabbit. In parallel,
nitrite/nitrate levels of carotid artery tissues, the metabolites
of nitric oxide, were decreased at the end of 4 weeks of
cholesterol feeding period which suggests that hypercholes-
terolemia attenuates both the production and bioavailability
of nitric oxide [26].
Recent studies have shown the restoration of endothelial
function by statins before signiﬁcant reduction of serum6 The Scientiﬁc World Journal
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Figure 4: The eﬀects of inhibition of nitric oxide synthesis by LNA and cyclooxygenase inhibition by INDO on the contractile responses to
serotonin in isolated rabbit carotid artery. Figures from control group (a, d), cholesterol group (b, e), and cholesterol + ﬂuvastatin group (c,
f). Ring presentations of carotid arteries from −LNA or −INDO ()( n = 5 )a n d+ L N Ao r+ I N D O( )( n = 5) in the groups. Values are
expressed as means ± S.E.M. ∗P<0.05 compared with −LNA and +LNA or −INDO and +INDO in the groups, Wilcoxon paired signed
ranks test.The Scientiﬁc World Journal 7
cholesterol levels, indicating the possibility of another/other
mechanism(s), independent of cholesterol reduction [10].
These direct eﬀects of statins on the endothelium were ﬁrst
deﬁned by their ability to enhance endothelial NO pro-
duction, upregulating endothelial NO synthase (eNOS)
[27, 28]. In our study, consistent with previous reports,
ﬂuvastatin treatment restored the impaired relaxations to
ACh in cholesterol-fedrabbits [29,30].Moreover, ﬂuvastatin
normalized the nitrite/nitrate levels of carotid artery tissues.
These ﬁndings possibly suggest a protective role of the drug
on the NO bioavailability in vascular wall [31].
As discussed above, along with the alterations of ACh-
induced relaxations, the present study demonstrated that
contractile responses to 5-HT were signiﬁcantly enhanced
in carotid arteries from high cholesterol fed rabbits without
any change in pD2 values, pointing to the fact that high
cholesterol diet did not aﬀect the sensitivity of serotonergic
receptors. Increased 5-HT-induced contractions have been
reported in high-fat-diet-fed rat thoracic aorta [32]a n dr a b -
bitaorta[33]andindiabeticrabbitcarotidartery[17].These
enhanced contractile responses to 5-HT have been attributed
to receptor-mediated or nonreceptor-mediated pathways.
As seen in Figure 2, the role of non-receptor mediated
contraction can be ruled out since there was no change
in contractile response to KCl in carotid arteries from all
groups. It has been speculated that the increased con-
tractions to 5-HT can be related to 5-HT2A upregulation
in spontaneously hypertensive rats [34]. Miranda et al.
reported the modulatory role of the endothelium in the
constrictor response of rabbit carotid artery to 5-HT by
releasing NO [17]. Thus, in our study, the increased 5-
HT responses may be due to diminished NO response be-
cause of the high cholesterol diet. Indeed, as seen, Figures
4(a), 4(b),a n d4(c), inhibition of NO synthesis by LNA
in rings from all groups revealed that endothelial NO
plays an important role in cholesterol-induced alterations
in vascular serotonergic responses. Similarly, as seen in
Figures 4(d), 4(e),a n d4(f), inhibition of cyclooxygenase
products by indomethacin did not aﬀect 5-HT receptor-
mediated responses in carotid arteries. On the other hand,
ﬂuvastatin restored the augmented contractile responses to
5-HT in carotid artery rings, as seen in Figures 3 and 4.
As discussed above, the results of these ﬁndings from in
vitro functional studies have suggested that ﬂuvastatin may
enhanceendothelialNOproduction.However,inthepresent
study, we did not determine the levels of nitrated proteins,
that is, nitrotyrosine and eNOS expression by using any
other method such as immunoblotting and western blotting.
In this regard, this eﬀect of ﬂuvastatin should be further
investigated.
In this study, while the SOD activity was increased by
cholesterol feeding, the catalase activity was found to be
decreased. Various studies reported diﬀerent results in SOD
activity in hypercholesterolemic conditions [35–39]. Thus,
the activity of this enzyme may be related to the extent and
duration of hypercholesterolemic diet. In our study, since
ﬂuvastatin signiﬁcantly lowered the increased SOD activity
by cholesterol diet, we proposed that the enhanced activity
of SOD in carotid artery tissues may be related to the change
in NO levels.
In conclusion, this study suggests that ﬂuvastatin, inde-
pendent of its lipid lowering properties, has a protective ef-
fect on the endothelial responses, which are compromised
after cholesterol feeding.
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